Drugmakers are increasingly turning to inhalable versions of vaccines and drugs in order to avoid the hassle and danger of syringes. A new inhaler that costs only four cents could administer powdered drugs as effectively as traditional inhalers that cost 10 times as much. The technology, which uses no moving parts, could help poor countries stop relying on syringes, which cost pennies apiece but require trained staff and carry an infection risk. To make their inhaler cheaper, engineers at Cambridge Consultants of Cambridge, England, and Boston focused on its internal shape. When a user inhales, a kind of miniature tornado forms inside the device, lifting a powdered drug into the air. The company is in talks with pharmaceutical firms to test the device with a powdered flu vaccine, among other drugs. Though an inhaler is a fraction of the price of a vaccine dose (currently $3 to $7), the savings could make a difference. “Everyone in the field dreams of a future with these kinds of simple, low-cost vaccine delivery systems,” says Donald Francis, cofounder of Global Solutions for Infectious Diseases, a nonprofit vaccine developer. “Moving to a needle-free model is a goal most of us share.”
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.